Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia or Schizoaffective”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01490086
What this trial is testing

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Acute SchizophreniaSchizoaffective Disorder
Reviva Pharmaceuticals 234
Post-approval studies (Phase 4)Study completedNCT00325689
What this trial is testing

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Who this might be right for
SchizophreniaSchizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 323
Large-scale testing (Phase 3)Study completedNCT00236457
What this trial is testing

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629
Large-scale testing (Phase 3)WithdrawnNCT06878833
What this trial is testing

Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Lyndra Inc.
Not applicableStudy completedNCT03571685
What this trial is testing

Sustainable Early Episode Clinic Study (SEEC)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen Scientific Affairs, LLC 50
Post-approval studies (Phase 4)Study completedNCT00526877
What this trial is testing

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Who this might be right for
SchizophreniaSchizoaffective Disorders
Johnson & Johnson Taiwan Ltd 31
Large-scale testing (Phase 3)Study completedNCT00641745
What this trial is testing

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 629
Not applicableStudy completedNCT03389425
What this trial is testing

Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study

Who this might be right for
ObesityAbdominal Obesity
University of Calgary 9
Large-scale testing (Phase 3)Study completedNCT00714818
What this trial is testing

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizoaffective Disorder
University of British Columbia 13
Post-approval studies (Phase 4)Study completedNCT00373672
What this trial is testing

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 58
Not applicableStudy completedNCT02819349
What this trial is testing

Texting for Relapse Prevention

Who this might be right for
SchizophreniaSchizoaffective Disorder
Center for Innovative Public Health Research 40
Post-approval studies (Phase 4)Study completedNCT00992407
What this trial is testing

An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 75
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Early research (Phase 1)Study completedNCT01082250
What this trial is testing

The Bioequivalence Of Two Different Lurasidone Formulations In Patients

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 52
Large-scale testing (Phase 3)Study completedNCT00236548
What this trial is testing

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
Large-scale testing (Phase 3)Study completedNCT00212771
What this trial is testing

Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Organon and Co 440
Post-approval studies (Phase 4)Study completedNCT00224315
What this trial is testing

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Central Institute of Mental Health, Mannheim 24
Not applicableUnknownNCT03240380
What this trial is testing

Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care.

Who this might be right for
SchizophreniaBipolar DisorderSchizoaffective Disorder
Universitätsklinikum Hamburg-Eppendorf 374
Large-scale testing (Phase 3)Study completedNCT00495118
What this trial is testing

A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 314
Post-approval studies (Phase 4)Study completedNCT00177580
What this trial is testing

Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Pittsburgh 72
Next Page